Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) shares dropped 0.1% during trading on Wednesday. The stock traded as low as $0.6925 and last traded at $0.8853. Approximately 2,105 shares changed hands during trading, a decline of 77% from the average session volume of 9,053 shares. The stock had previously closed at $0.8860.
Peak Pharmaceuticals Price Performance
The firm has a fifty day moving average of $0.99 and a 200 day moving average of $1.00.
About Peak Pharmaceuticals
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
Read More
- Five stocks we like better than Peak Pharmaceuticals
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
